Eli Lilly and Company — Ethics Grade C-

Eli Lilly and Company receives an overall ethics grade of C- (40/100) on CancelCo's corporate accountability database. Sector: Pharmaceuticals. Market cap: Mega Cap.

Category scores

• labor: 55
• privacy: 60
• consumer: 15
• environment: 55
• humanRights: 40

Documented incidents (2)

• Insulin price gouging (high, 2023) — Charged $275/vial for insulin costing $10 to produce, contributing to rationing and deaths among diabetic patients for decades.
• Illegal off-label drug marketing (high, 2009) — Paid $1.4B to settle charges of illegally marketing Zyprexa for unapproved uses in elderly patients.

Documented good deeds

• Insulin price cap at $35 — Capped insulin prices at $35/month for insured patients and reduced list prices by 70%.

Ethical alternatives

• Civica Rx — Non-profit producing affordable insulin and generic medications at transparent prices.